Interferon-γ independently activates the MHC class I antigen processing pathway and diminishes glucose responsiveness in pancreatic β-cell lines

Manuel E. Baldeón, David J. Neece, Dipankar Nandi, John J. Monaco, H Rex Gaskins

Research output: Contribution to journalArticle

Abstract

The mouse pancreatic βTC3 and βTC6-F7 cell lines were used to characterize the effects of interferon-γ (IFN-γ) on β-cell phenotype and function. Initially, intracellular and secreted insulin were compared in glucose-stimulated cells over time. A significant reduction in insulin content and secretion was observed on a per-cell basis in glucose-stimulated βTC3 and βTC6-F7 cells after 12 h of exposure to IFN-γ. The steady-state level of pre-proinsulin mRNA expression was not affected by IFN-γ. Thus, we postulate that IFN-γ's inhibitory actions occur after transcription of preproinsulin genes. Time-course analysis of IFN-γ-regulated mRNA expression of the two intra-MHC-encoded subunits of the proteasome (low-molecular-mass polypeptide [Lmp]-2 and Lmp-7) revealed a correlation between their induction and the inhibitory effects of IFN-γ on glucose-stimulated insulin production. Increased expression of Lmp-2 and Lmp-7 mRNA was accompanied by a corresponding induction of LMP2 and LMP7 protein expression. Subsequently, major histocompatibility complex (MHC) class I cell-surface expression was significantly increased in IFN-γ-treated βTC3 and βTC6-F7 cells. Exposure of IFN-γ-treated β-cells to a peptide aldehyde inhibitor of the proteasome (MG132) significantly attenuated MHC class I cell-surface expression but did not prevent the negative effects of IFN-γ on glucose responsiveness. Enhanced expression of the MHC class I antigen processing and presentation pathway and diminished insulin production appear to be distinct pathological alterations in β-cells exposed to the insulitic cytokine IFN-γ.

Original languageEnglish (US)
Pages (from-to)770-778
Number of pages9
JournalDiabetes
Volume46
Issue number5
StatePublished - May 1 1997

Fingerprint

Histocompatibility Antigens Class I
Antigen Presentation
Major Histocompatibility Complex
Interferons
Glucose
Cell Line
Insulin
Peptides
Messenger RNA
Proteasome Inhibitors
RNA Precursors
Proteasome Endopeptidase Complex
Aldehydes
Cytokines
Phenotype

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Interferon-γ independently activates the MHC class I antigen processing pathway and diminishes glucose responsiveness in pancreatic β-cell lines. / Baldeón, Manuel E.; Neece, David J.; Nandi, Dipankar; Monaco, John J.; Gaskins, H Rex.

In: Diabetes, Vol. 46, No. 5, 01.05.1997, p. 770-778.

Research output: Contribution to journalArticle

Baldeón, Manuel E. ; Neece, David J. ; Nandi, Dipankar ; Monaco, John J. ; Gaskins, H Rex. / Interferon-γ independently activates the MHC class I antigen processing pathway and diminishes glucose responsiveness in pancreatic β-cell lines. In: Diabetes. 1997 ; Vol. 46, No. 5. pp. 770-778.
@article{36bc33cef1224b32b15ef0a0330e72e3,
title = "Interferon-γ independently activates the MHC class I antigen processing pathway and diminishes glucose responsiveness in pancreatic β-cell lines",
abstract = "The mouse pancreatic βTC3 and βTC6-F7 cell lines were used to characterize the effects of interferon-γ (IFN-γ) on β-cell phenotype and function. Initially, intracellular and secreted insulin were compared in glucose-stimulated cells over time. A significant reduction in insulin content and secretion was observed on a per-cell basis in glucose-stimulated βTC3 and βTC6-F7 cells after 12 h of exposure to IFN-γ. The steady-state level of pre-proinsulin mRNA expression was not affected by IFN-γ. Thus, we postulate that IFN-γ's inhibitory actions occur after transcription of preproinsulin genes. Time-course analysis of IFN-γ-regulated mRNA expression of the two intra-MHC-encoded subunits of the proteasome (low-molecular-mass polypeptide [Lmp]-2 and Lmp-7) revealed a correlation between their induction and the inhibitory effects of IFN-γ on glucose-stimulated insulin production. Increased expression of Lmp-2 and Lmp-7 mRNA was accompanied by a corresponding induction of LMP2 and LMP7 protein expression. Subsequently, major histocompatibility complex (MHC) class I cell-surface expression was significantly increased in IFN-γ-treated βTC3 and βTC6-F7 cells. Exposure of IFN-γ-treated β-cells to a peptide aldehyde inhibitor of the proteasome (MG132) significantly attenuated MHC class I cell-surface expression but did not prevent the negative effects of IFN-γ on glucose responsiveness. Enhanced expression of the MHC class I antigen processing and presentation pathway and diminished insulin production appear to be distinct pathological alterations in β-cells exposed to the insulitic cytokine IFN-γ.",
author = "Balde{\'o}n, {Manuel E.} and Neece, {David J.} and Dipankar Nandi and Monaco, {John J.} and Gaskins, {H Rex}",
year = "1997",
month = "5",
day = "1",
language = "English (US)",
volume = "46",
pages = "770--778",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "5",

}

TY - JOUR

T1 - Interferon-γ independently activates the MHC class I antigen processing pathway and diminishes glucose responsiveness in pancreatic β-cell lines

AU - Baldeón, Manuel E.

AU - Neece, David J.

AU - Nandi, Dipankar

AU - Monaco, John J.

AU - Gaskins, H Rex

PY - 1997/5/1

Y1 - 1997/5/1

N2 - The mouse pancreatic βTC3 and βTC6-F7 cell lines were used to characterize the effects of interferon-γ (IFN-γ) on β-cell phenotype and function. Initially, intracellular and secreted insulin were compared in glucose-stimulated cells over time. A significant reduction in insulin content and secretion was observed on a per-cell basis in glucose-stimulated βTC3 and βTC6-F7 cells after 12 h of exposure to IFN-γ. The steady-state level of pre-proinsulin mRNA expression was not affected by IFN-γ. Thus, we postulate that IFN-γ's inhibitory actions occur after transcription of preproinsulin genes. Time-course analysis of IFN-γ-regulated mRNA expression of the two intra-MHC-encoded subunits of the proteasome (low-molecular-mass polypeptide [Lmp]-2 and Lmp-7) revealed a correlation between their induction and the inhibitory effects of IFN-γ on glucose-stimulated insulin production. Increased expression of Lmp-2 and Lmp-7 mRNA was accompanied by a corresponding induction of LMP2 and LMP7 protein expression. Subsequently, major histocompatibility complex (MHC) class I cell-surface expression was significantly increased in IFN-γ-treated βTC3 and βTC6-F7 cells. Exposure of IFN-γ-treated β-cells to a peptide aldehyde inhibitor of the proteasome (MG132) significantly attenuated MHC class I cell-surface expression but did not prevent the negative effects of IFN-γ on glucose responsiveness. Enhanced expression of the MHC class I antigen processing and presentation pathway and diminished insulin production appear to be distinct pathological alterations in β-cells exposed to the insulitic cytokine IFN-γ.

AB - The mouse pancreatic βTC3 and βTC6-F7 cell lines were used to characterize the effects of interferon-γ (IFN-γ) on β-cell phenotype and function. Initially, intracellular and secreted insulin were compared in glucose-stimulated cells over time. A significant reduction in insulin content and secretion was observed on a per-cell basis in glucose-stimulated βTC3 and βTC6-F7 cells after 12 h of exposure to IFN-γ. The steady-state level of pre-proinsulin mRNA expression was not affected by IFN-γ. Thus, we postulate that IFN-γ's inhibitory actions occur after transcription of preproinsulin genes. Time-course analysis of IFN-γ-regulated mRNA expression of the two intra-MHC-encoded subunits of the proteasome (low-molecular-mass polypeptide [Lmp]-2 and Lmp-7) revealed a correlation between their induction and the inhibitory effects of IFN-γ on glucose-stimulated insulin production. Increased expression of Lmp-2 and Lmp-7 mRNA was accompanied by a corresponding induction of LMP2 and LMP7 protein expression. Subsequently, major histocompatibility complex (MHC) class I cell-surface expression was significantly increased in IFN-γ-treated βTC3 and βTC6-F7 cells. Exposure of IFN-γ-treated β-cells to a peptide aldehyde inhibitor of the proteasome (MG132) significantly attenuated MHC class I cell-surface expression but did not prevent the negative effects of IFN-γ on glucose responsiveness. Enhanced expression of the MHC class I antigen processing and presentation pathway and diminished insulin production appear to be distinct pathological alterations in β-cells exposed to the insulitic cytokine IFN-γ.

UR - http://www.scopus.com/inward/record.url?scp=0031002802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031002802&partnerID=8YFLogxK

M3 - Article

C2 - 9133543

AN - SCOPUS:0031002802

VL - 46

SP - 770

EP - 778

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 5

ER -